April 22, 2013

The Wall Street Journal

Data Show Over 80 Percent of Patients Report Ongoing Improvement or Complete Elimination of GERD Symptoms Two Years after Transoral Incisionless Fundoplication

Long-Term Outcomes from TIF US Registry Presented at 2013 SAGES Annual Meeting

REDWOOD CITY, Calif.--(BUSINESS WIRE)--April 22, 2013-- EndoGastric Solutions(R) (EGS), the leader in endoluminal reconstructive treatment for Gastroesophageal Reflux Disease (GERD), today announced the presentation of two-year data from the Transoral Incisionless Fundoplication (TIF(R)) US Registry at the 2013 SAGES Annual Meeting during the therapeutic endoscopy scientific session in Baltimore, Maryland.

The TIF procedure was safe and effective in eliminating or improving a range of typical and atypical GERD symptoms, including heartburn and reflux, in up to 81% of patients in the study. Also, in 81% of patients undergoing endoscopy 24 months after their TIF procedure, esophagitis was fully healed or notably improved.

"This two-year data demonstrates the long-term value of a transoral anatomic correction in the treatment of GERD patients with mild to moderate disease. We are very encouraged by the sustained response seen by patients with either typical or atypical symptoms," said Mike Kleine, President and CEO of EGS.

Twenty-four months after the EsophyX(2) (R) device was used in TIF procedures, more than two-thirds of patients completely eliminated the need for daily proton pump inhibitor (PPIs) therapy. Symptom control achieved at six months remained stable over time, indicating durability of the TIF procedure.

"The TIF procedure is an attractive option because it dramatically shifts the risk-benefit ratio associated with correcting the underlying anatomical defect and allows a majority of patients to stop taking daily medication for reflux," said Karim Trad, MD, FACS, SAGES presenter and an investigator in this prospective multicenter registry of patients with chronic GERD.

To read the full article, visit:  http://online.wsj.com/article/PR-CO-20130422-905274.html?mod=googlenews_wsj